Metric Finance
LearnFAQ
LearnFAQ

Learn / SNDX

NASDAQ: SNDX

Syndax Pharmaceuticals (SNDX) stock, explained like you're 5

Syndax Pharmaceuticals trades on the Nasdaq under the ticker SNDX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.

Ticker
SNDX
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.5 billion dollars

Is Syndax Pharmaceuticals a small, medium or large cap company?

No. Syndax Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.5 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Syndax Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves SNDX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Syndax Pharmaceuticals (SNDX) Stock May Be Fully Priced After Trial Setback (Simply Wall Street)
  • Syndax Pharmaceuticals Stock Plunges. A Failed Trial Deals Blow to Growth Plans. (Barron's)
  • Syndax Pharmaceuticals stock hits 52 week low at 12.98 USD (Investing.com)
  • Syndax Pharmaceuticals (SNDX) Stock Forecast and Price Target 2026 (MarketBeat)
  • Syndax Pharmaceuticals (SNDX) Is Down 7.2% After Axatilimab IPF Trial Misses Endpoint Has The Bull Case Changed? (Yahoo Finance)

Follow SNDX in your daily brief

Each trading day at 5 PM ET we post what happened to Syndax Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow SNDX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Syndax Pharmaceuticals stock

What does Syndax Pharmaceuticals do?

Syndax Pharmaceuticals trades on the Nasdaq under the ticker SNDX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.

What is the ticker symbol for Syndax Pharmaceuticals?

Syndax Pharmaceuticals trades under the ticker SNDX on the Nasdaq.

What is Syndax Pharmaceuticals's market cap?

Syndax Pharmaceuticals is a small cap stock with a market cap of about 1.5 billion dollars.

How does Syndax Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves SNDX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow SNDX stock every day?

Add SNDX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow SNDX daily

A free brief on Syndax Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare SNDX: SNDX vs NVS, SNDX vs AZN, SNDX vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed